Amneal Pharmaceuticals, Inc. (AMRX) insider trading

By person

16 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Tushar Bhikhubhai Patel

10% owner

—

61,341,678

$1.08B

+14.5%

Chirag K. Patel

President & Co-CEO

—

7,775,204

$137.15M

+1,417%

Chintu Patel

Co-CEO

—

7,770,255

$137.07M

+1,416%

Gautam Patel

Director

—

1,927,595

$34.00M

−5.9%

Paul M Meister

Director

—

832,800

$14.69M

+14.4%

Tasos Konidaris

Executive Vice President & CFO

—

449,434

$7.93M

−14.8%

Jeffrey P. George

Director

—

344,614

$6.08M

+27.9%

Ted C Nark

Director

—

325,848

$5.75M

+8.3%

Shlomo Yanai

Director

—

320,804

$5.66M

+30.6%

J Kevin Buchi

Director

—

282,520

$4.98M

−55.7%

Nikita Shah

Executive Vice President

—

253,390

$4.47M

−13.1%

Emily Peterson Alva

Director

—

211,029

$3.72M

−15.8%

John Kiely

Director

—

200,252

$3.53M

−21.7%

Andrew S Boyer

Executive Vice President

—

193,646

$3.42M

−24.6%

Deborah M. Autor

Director

—

93,660

$1.65M

+0.3%

Jason B. Daly

EVP, Chief Legal Officer

—

35,171

$620.42K

−38.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Amneal Pharmaceuticals, Inc.

What the insiders did No buying or selling

By person